ES406590A1 - Procedimiento para la vacunacion preventiva contra viruela. - Google Patents

Procedimiento para la vacunacion preventiva contra viruela.

Info

Publication number
ES406590A1
ES406590A1 ES406590A ES406590A ES406590A1 ES 406590 A1 ES406590 A1 ES 406590A1 ES 406590 A ES406590 A ES 406590A ES 406590 A ES406590 A ES 406590A ES 406590 A1 ES406590 A1 ES 406590A1
Authority
ES
Spain
Prior art keywords
contg
vaccinia virus
attenuated vaccinia
smallpox vaccine
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES406590A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAYERN FREISTAAT
Original Assignee
BAYERN FREISTAAT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by BAYERN FREISTAAT filed Critical BAYERN FREISTAAT
Publication of ES406590A1 publication Critical patent/ES406590A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES406590A 1971-09-11 1972-09-11 Procedimiento para la vacunacion preventiva contra viruela. Expired ES406590A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (1)

Publication Number Publication Date
ES406590A1 true ES406590A1 (es) 1975-09-16

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
ES406590A Expired ES406590A1 (es) 1971-09-11 1972-09-11 Procedimiento para la vacunacion preventiva contra viruela.

Country Status (5)

Country Link
AT (1) AT320149B (es)
BE (1) BE787901A (es)
CH (1) CH568392A5 (es)
DK (1) DK137392C (es)
ES (1) ES406590A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
US7473536B2 (en) 2002-08-07 2009-01-06 Bavarian Nordic A/S Isolated avian cell that expresses Vaccinia virus host range genes
CA2520637A1 (en) 2003-03-28 2004-10-14 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Mva virus expressing modified hiv envelope, gag, and pol genes
DK1789438T3 (en) 2004-08-27 2015-07-20 Us Government Recombinant MVA viruses expressing MODIFIED env, gag and pol genes of HIV CLADE A / G, CLADE CLADE B AND C
JP2010526546A (ja) 2007-05-14 2010-08-05 バヴァリアン・ノルディック・アクティーゼルスカブ ワクシニアウイルス系及び組換えワクシニアウイルス系ワクチンの精製
AU2010305030A1 (en) 2009-10-08 2012-05-10 Bavarian Nordic A/S Generation of a broad T-cell response in humans against HIV
US10087423B2 (en) 2010-07-20 2018-10-02 Bavarian Nordic A/S Method for harvesting expression products
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
US11278607B2 (en) 2016-01-08 2022-03-22 Geovax, Inc. Compositions and methods for generating an immune response to a tumor associated antigen
EP4058058A1 (en) 2019-11-14 2022-09-21 Aelix Therapeutics S.L. Dosage regimens for vaccines
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
WO2022269003A1 (en) 2021-06-23 2022-12-29 Consejo Superior De Investigaciones Cientificas MVA-BASED VACCINE EXPRESSING A PREFUSION-STABILIZED SARS-CoV-2 S PROTEIN
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein

Also Published As

Publication number Publication date
DK137392B (da) 1978-02-27
DE2145477B2 (de) 1976-04-01
AT320149B (de) 1975-01-27
BE787901A (fr) 1972-12-18
CH568392A5 (es) 1975-10-31
DE2145477A1 (de) 1973-03-15
DK137392C (da) 1978-09-18

Similar Documents

Publication Publication Date Title
ES406590A1 (es) Procedimiento para la vacunacion preventiva contra viruela.
SE389331B (sv) Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
IL40495A (en) Poly 2'-fluoro-2'-deoxyuridylic acid,its preparation and its use as an enzyme inhibitor and the monomer 2'-fluoro-2'-deoxyuridine-5'-diphosphate
GB1501724A (en) Highly attenuated cytomegalovirus vaccine and production thereof
CA924330A (en) High purity hot pressed boron nitride
IT7822442A0 (it) Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi.
ES426215A1 (es) Procedimiento para preparar una vacuna de adenovirus bovi- nos vivos.
CA957168A (en) Steam system
ES398622A1 (es) Perfeccionamientos en planchas de vapor y secas.
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
CA970110A (en) Low-froth, water-soluble dyeing auxiliaries
AU465928B2 (en) Transfer dyeing under reduced pressure
AU4243872A (en) Steam pressure cooker
SE417097B (sv) 2,4 diamino-5 bensylpyrimidiner till anvendning som mellanprodukter for framstellning av 2,4 diamino-5 bensylpyrimidiner och sett att framstella dem
CA949408A (en) Steam boiler
CA1007567A (en) Vaccine adjuvants
AU3252271A (en) Vaccine preparation
SU77221A1 (ru) Терморегул тор, преимущественно дл муфельной печи
CA1030449A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
CA952169A (en) Skin heating of steel by a.c.
DK134518B (da) Analogifremgangsmåde til fremstilling af 4beta-alkoxy-4alfa-(3'-hydroxyphenyl)-3alfa,5alfa-propanopiperidin-derivater.
CA876717A (en) 2,4 disubstituted tetrahydro 1,4-oxazines
AU461179B2 (en) Steam chamber
AU452829B2 (en) Anhydrous smallpox vaccine and process for producing it
DK134987B (da) Fremgangsmåde til fremstilling af 4,4'-ditert.-butyl-benzoylperoxid.